In a recent discovery, readily available PET scanning can now carry out a complete body review of the impacts of STING, activating procedure in human beings.
The news comes from the University of Los Angeles. In short, this discovery indicates that the medical world has a new tool that can function as a diagnostic tool to analyze the clinical outcome of STING technology effectively.
STING (stimulator of interferon genes) is used to control immune activation. Due to this capability, drugs promoting these genes can be an active part of cancer treatment. Significant experiments are taking place in this field. However, the use of STING is not limited to the treatment of cancer. Instead, it is also perfect to use in treating other infections.
The discovery suggests that PET imaging extends a highly accessible approach to analyzing the clinical effects of STING-boosting drugs.
READ MORE: Innovative Bioadhesive Ultrasound Helps to Image Organs Continuously Over Long Periods of Time
The University of California led the research; Los Angeles (UCLA) ‘s Jonsson Comprehensive Cancer Investigators analyzed if systemic STING activation induces metabolic changes in immunity-promoting cells, which the PET imaging technique can visualize.
“A new generation of STING agonists have broadened the available routes of administration to include systemic immune activation and are thus moving quickly in the clinical setting of cancer immunotherapy,” informs Hailey Lee, first co-author of the research
The most critical use of PET as an imaging tool would be to review the effects of the STING technique in such a way that the possibility of over-dose is less.